X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs UNICHEM LAB - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD UNICHEM LAB ALEMBIC LTD/
UNICHEM LAB
 
P/E (TTM) x 55.4 -280.6 - View Chart
P/BV x 3.1 2.1 151.1% View Chart
Dividend Yield % 0.4 1.2 29.0%  

Financials

 ALEMBIC LTD   UNICHEM LAB
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
UNICHEM LAB
Mar-17
ALEMBIC LTD/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs53320 16.5%   
Low Rs29221 13.3%   
Sales per share (Unadj.) Rs4.7167.2 2.8%  
Earnings per share (Unadj.) Rs8.812.0 73.4%  
Cash flow per share (Unadj.) Rs9.016.9 53.2%  
Dividends per share (Unadj.) Rs0.153.00 5.0%  
Dividend yield (eoy) %0.41.1 32.9%  
Book value per share (Unadj.) Rs27.7117.0 23.7%  
Shares outstanding (eoy) m267.0390.88 293.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.71.6 537.7%   
Avg P/E ratio x4.722.6 20.7%  
P/CF ratio (eoy) x4.616.0 28.5%  
Price / Book Value ratio x1.52.3 64.1%  
Dividend payout %1.725.1 6.8%   
Avg Mkt Cap Rs m10,96224,578 44.6%   
No. of employees `000NA5.2 0.0%   
Total wages/salary Rs m2382,487 9.6%   
Avg. sales/employee Rs ThNM2,928.3-  
Avg. wages/employee Rs ThNM479.4-  
Avg. net profit/employee Rs ThNM209.4-  
INCOME DATA
Net Sales Rs m1,26015,195 8.3%  
Other income Rs m264110 239.4%   
Total revenues Rs m1,52415,305 10.0%   
Gross profit Rs m831,788 4.6%  
Depreciation Rs m61452 13.6%   
Interest Rs m034 0.9%   
Profit before tax Rs m2851,413 20.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m6326 1.9%   
Profit after tax Rs m2,3431,087 215.6%  
Gross profit margin %6.611.8 55.8%  
Effective tax rate %2.123.1 9.3%   
Net profit margin %185.97.2 2,599.1%  
BALANCE SHEET DATA
Current assets Rs m1,6896,426 26.3%   
Current liabilities Rs m4863,917 12.4%   
Net working cap to sales %95.416.5 578.0%  
Current ratio x3.51.6 211.7%  
Inventory Days Days21768 320.6%  
Debtors Days Days8177 105.3%  
Net fixed assets Rs m1,6247,410 21.9%   
Share capital Rs m534182 293.8%   
"Free" reserves Rs m5,96010,454 57.0%   
Net worth Rs m7,40410,636 69.6%   
Long term debt Rs m1044 2,370.5%   
Total assets Rs m8,01015,258 52.5%  
Interest coverage x950.742.9 2,215.1%   
Debt to equity ratio x00 3,405.3%  
Sales to assets ratio x0.21.0 15.8%   
Return on assets %29.37.3 398.3%  
Return on equity %31.610.2 309.7%  
Return on capital %31.313.6 230.2%  
Exports to sales %2.924.1 12.2%   
Imports to sales %28.94.9 583.4%   
Exports (fob) Rs m373,666 1.0%   
Imports (cif) Rs m364752 48.4%   
Fx inflow Rs m375,298 0.7%   
Fx outflow Rs m3650-   
Net fx Rs m-3285,298 -6.2%   
CASH FLOW
From Operations Rs m346683 50.6%  
From Investments Rs m-48-1,316 3.6%  
From Financial Activity Rs m-301592 -50.8%  
Net Cashflow Rs m-3-40 7.5%  

Share Holding

Indian Promoters % 64.0 50.1 127.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 15.1 1.3%  
FIIs % 9.7 3.0 323.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 31.7 82.3%  
Shareholders   54,701 20,176 271.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   STRIDES SHASUN LTD  AJANTA PHARMA  SUVEN LIFE  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jun 21, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - LUPIN LTD COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS